Morpholino-Talinolol

Derivative of Talinolol unselective antagonist of the beta adrenergic receptors (betaAR). Much better inhibitor of soluble epoxide hydrolase than talinolol IC50 0.077+/-0.004 muM

General

Type : Urea derivative,Not A\/B H target,Adrenergic-Receptor-ligand,Morpholine,tert-Butyl

Chemical_Nomenclature : 1-[4-[[(2S)-4-tert-butylmorpholin-2-yl]methoxy]phenyl]-3-cyclohexylurea

Canonical SMILES : CC(C)(C)N1CCOC(C1)COC2=CC=C(C=C2)NC(=O)NC3CCCCC3

InChI : InChI=1S\/C22H35N3O3\/c1-22(2,3)25-13-14-27-20(15-25)16-28-19-11-9-18(10-12-19)24-21(26)23-17-7-5-4-6-8-17\/h9-12,17,20H,4-8,13-16H2,1-3H3,(H2,23,24,26)\/t20-\/m0\/s1

InChIKey : PSVUAGRHPQWOOO-FQEVSTJZSA-N

Other name(s) : G3T


MW : 389.53

Formula : C22H35N3O3

CAS_number :

PubChem : 138454247

UniChem : PSVUAGRHPQWOOO-FQEVSTJZSA-N

IUPHAR :

Wikipedia :

Target

Families : Morpholino-Talinolol ligand of proteins in family: Epoxide_hydrolase

Stucture : 6HGX Human soluble epoxide hydrolase in complex with 1-(4-((4-(tert-butyl)morpholin-2-yl)methoxy)phenyl)-3-cyclohexylurea

Protein : human-EPHX2

References (1)

Title : Computer-Aided Selective Optimization of Side Activities of Talinolol - Hiesinger_2019_ACS.Med.Chem.Lett_10_899
Author(s) : Hiesinger K , Kramer JS , Achenbach J , Moser D , Weber J , Wittmann SK , Morisseau C , Angioni C , Geisslinger G , Kahnt AS , Kaiser A , Proschak A , Steinhilber D , Pogoryelov D , Wagner K , Hammock BD , Proschak E
Ref : ACS Med Chem Lett , 10 :899 , 2019
Abstract : Hiesinger_2019_ACS.Med.Chem.Lett_10_899
ESTHER : Hiesinger_2019_ACS.Med.Chem.Lett_10_899
PubMedSearch : Hiesinger_2019_ACS.Med.Chem.Lett_10_899
PubMedID: 31223445
Gene_locus related to this paper: human-EPHX2